117 related articles for article (PubMed ID: 25316005)
21. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
23. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
[TBL] [Abstract][Full Text] [Related]
24. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
[TBL] [Abstract][Full Text] [Related]
26. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
[TBL] [Abstract][Full Text] [Related]
27. Hyperbaric oxygen therapy for late radiation-associated tissue necroses: is it safe in patients with locoregionally recurrent and then successfully salvaged head-and-neck cancers?
Lin HY; Ku CH; Liu DW; Chao HL; Lin CS; Jen YM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1077-82. PubMed ID: 19327913
[TBL] [Abstract][Full Text] [Related]
28. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
29. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
Grimard L; Esche B; Lamothe A; Cygler J; Spaans J
Head Neck; 2006 Oct; 28(10):888-95. PubMed ID: 16721742
[TBL] [Abstract][Full Text] [Related]
30. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
31. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J
Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985
[TBL] [Abstract][Full Text] [Related]
32. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
33. Reirradiation for recurrent head and neck carcinoma.
Peponi E; Balta S; Tasiou I; Gogou P; Capizzello A; Pitouli E; Tsekeris P
J BUON; 2012; 17(3):465-70. PubMed ID: 23033283
[TBL] [Abstract][Full Text] [Related]
34. Value of whole brain re-irradiation for brain metastases--single centre experience.
Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
[TBL] [Abstract][Full Text] [Related]
35. Brachytherapy in the retreatment of patients with new primary head and neck cancer.
Grimard L; Lamothe A; Esche B; Spaans JN
J Otolaryngol; 2007 Dec; 36(6):327-35. PubMed ID: 18076842
[TBL] [Abstract][Full Text] [Related]
36. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
40. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
